XTX Topco’s Roivant Sciences ROIV Stock Holding History

XTX Topco’s Portfolio ROIV Stock Details ROIV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$5.92M	Sell	167,264 -88,167	-35%	-$2.61M	0.08%	308
2026 Q1	$7.08M	Buy	+255,431	New	+$6.56M	0.12%	148
2025 Q4	–	Sell	-70,519	Closed	-$1.07M	–	3719
2025 Q3	$1.07M	Buy	+70,519	New	+$873K	0.06%	544
2025 Q2	–	Sell	-256,714	Closed	-$2.59M	–	3042
2025 Q1	$2.59M	Buy	256,714 +221,742	+634%	+$2.4M	0.13%	162
2024 Q4	$414K	Sell	34,972 -20,528	-37%	-$243K	0.03%	939
2024 Q3	$640K	Buy	55,500 +29,842	+116%	+$340K	0.05%	649
2024 Q2	$271K	Buy	+25,658	New	+$281K	0.02%	1031
2023 Q3	–	Sell	-11,672	Closed	-$118K	–	1945
2023 Q2	$118K	Buy	+11,672	New	+$104K	0.02%	1143
2023 Q1	–	Sell	-20,205	Closed	-$161K	–	1610
2022 Q4	$161K	Buy	+20,205	New	+$112K	0.03%	905

Other funds holding ROIV

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

QVT Financial New York $1.7B AUM 173.77% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

FCM

Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return

XTX Topco's ROIV Position: Q2 2026 in Review

XTX Topco reduced its Roivant Sciences (ROIV) stake by 35% in Q2 2026, selling an estimated $2.61M and leaving 167,264 shares worth $5.92M. The position accounts for 0.08% of the portfolio, ranked #308.

XTX Topco first reported a position in ROIV in Q4 2022 and has held it in 9 quarters since. The position peaked at $7.08M in Q1 2026. 498 funds tracked by Wall St. Rank hold ROIV as of Q2 2026.

XTX Topco held 167,264 shares of Roivant Sciences worth $5.92M as of Q2 2026.
XTX Topco sold 88,167 Roivant Sciences shares in Q2 2026, an estimated $2.61M.
Roivant Sciences made up 0.08% of XTX Topco's portfolio in Q2 2026, its #308 holding.
XTX Topco first reported a position in Roivant Sciences in Q4 2022 and has held it in 9 quarters since.
XTX Topco's Roivant Sciences position peaked at $7.08M in Q1 2026.
498 funds tracked by Wall St. Rank held Roivant Sciences as of Q2 2026.

Based on XTX Topco's 13F filing for Q2 2026, filed 14 Aug 2026.